Financial Services Industry Spends $1.7 Billion on Blockchain Jun 15, 2018 Financial Service, Technology
China National Drug Administration Approves Country’s First Immuno-Oncology Agent, Opdivo (nivolumab injection), for Previously Treated Non-Small Cell Lung Cancer (NSCLC) Jun 15, 2018 Life Science
Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity Jun 15, 2018 Life Science
Aptose Acquires China Rights to Leukemia Candidate in $125 Million Agreement Jun 15, 2018 Life Science
Chinese Digital Asset Investment Platform LendChain Raises Tens Of Millions Of RMB Jun 15, 2018 Technology
Sequoia Capital, Shunwei Lead $38M D Round In London-based IP Analytic Platform PatSnap Jun 14, 2018 Technology
